Treatment library
Loading treatment roster
Preparing current medications, procedures, devices, and historical context.
Treatment library
Preparing current medications, procedures, devices, and historical context.
Lorcaserin’s branded obesity-drug era ended after the FDA requested market withdrawal because a safety clinical trial found an increased occurrence of cancer.
FDA requested withdrawal of Belviq and Belviq XR from the U.S. market in February 2020.
Selective serotonin 2C receptor agonist
Not applicable as a current treatment option.
Selective serotonin 2C receptor agonist
Lorcaserin’s branded obesity-drug era ended after the FDA requested market withdrawal because a safety clinical trial found an increased occurrence of cancer.
legacy
discontinued
2012
2020
Belviq, Belviq XR
lorcaserin
Arena / Eisai (historical)
No current U.S. product.
lorcaserin
Discontinued product; not a current routine market option.
Not applicable as a current treatment option.
Historical reference only.
Belviq remains part of the treatment story because patients still search it and because its withdrawal altered confidence in older obesity-drug development.
Its main modern significance is the FDA cancer-signal withdrawal and the reminder that postmarket safety can upend a drug’s place in obesity care.
headache, dizziness, fatigue, nausea, cancer-signal withdrawal concern
Selective serotonin 2C receptor agonist
Historical oral dosing; no current routine U.S. use.
Historical oral tablet or extended-release tablet.
Discontinued obesity medication
Historical oral tablet or extended-release tablet.
Its main modern significance is the FDA cancer-signal withdrawal and the reminder that postmarket safety can upend a drug’s place in obesity care.
These are the official or reference sources used to anchor this treatment profile.
Treatment availability, dosing, cash pricing, and insurance coverage change often. Verify current details with your clinician, pharmacist, surgeon, device program, and insurer before starting, switching, or paying for treatment.